VANGUARD GROUP INC, a registered investment adviser, initiated a new position in Illumina, Inc. (NASDAQ:ILMN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 13,032,809 shares of the Healthcare company, valued at approximately $1.7B as of the filing date.
Illumina, Inc.'s stock currently trades at $148.67 with a market capitalization of $20.8B.